Department of Physiology and Pharmacology, School of Medicine, Health Science Center North West Virginia University, Morgantown, WV 26505-9229, USA.
Cardiovasc Res. 2010 Jul 15;87(2):340-7. doi: 10.1093/cvr/cvq006. Epub 2010 Jan 15.
In this study, we investigated the mechanisms by which caveolin-1 (CAV) inhibits increases in permeability induced by platelet activating factor (PAF) and elucidated the relationship between the endothelial intracellular Ca(2+) concentration (Ca(2+)) and CAV in regulating endothelial nitric oxide synthase (eNOS) activity and microvessel permeability in intact microvessels.
Experiments were conducted in individually perfused mesenteric venules in Sprague-Dawley rats. Permeability was determined by measuring hydraulic conductivity (Lp). Endothelial Ca(2+) and nitric oxide (NO) production were measured in fura-2- and DAF-2-loaded microvessels. Perfusion of the CAV scaffolding domain, AP-CAV, at 1 microM for 30 min did not affect PAF-induced increases in endothelial Ca(2+) but significantly attenuated PAF-induced NO production from 143 +/- 2 to 110 +/- 3% of control fluorescence intensity (FI). The PAF-induced Lp increase was correlatively reduced from a mean peak value of 7.5 +/- 0.9 to 1.9 +/- 0.5 times that of the control. Increasing extracellular [Ca(2+)] that potentiated PAF-induced peak Ca(2+) from 500 to 1225 nM augmented NO production to 193 +/- 13% and further increased Lp to 17.3 +/- 1.6 times the control value. More importantly, enhanced Ca(2+) influx restored the reduced NO production and Lp by AP-CAV with NO FI at 149% and Lp at 7.7 +/- 1.1 times the control value.
Our results indicate that eNOS inhibition and reduced NO production contribute to the inhibitory action of AP-CAV on PAF-induced increases in permeability. CAV and endothelial Ca(2+) antagonistically regulate eNOS activity in intact microvessels, and the level of produced NO is the key determinant of the degree of permeability increases during inflammation.
本研究旨在探讨窖蛋白-1(CAV)抑制血小板激活因子(PAF)诱导的通透性增加的机制,并阐明内皮细胞内钙离子浓度([Ca 2+ ] i )与调节内皮型一氧化氮合酶(eNOS)活性和完整微血管通透性的 CAV 之间的关系。
在 Sprague-Dawley 大鼠的单独灌注肠系膜小静脉中进行实验。通过测量水力传导率(Lp)来确定通透性。在 fura-2 和 DAF-2 负载的微血管中测量内皮细胞[Ca 2+ ] i 和一氧化氮(NO)的产生。用 1μM 的 CAV 支架结构域 AP-CAV 灌注 30 分钟不会影响 PAF 诱导的内皮细胞[Ca 2+ ] i 的增加,但显著减弱了 PAF 诱导的从 143±2 到 110±3%的对照荧光强度(FI)的 NO 产生。PAF 诱导的 Lp 增加从平均峰值 7.5±0.9 减少到对照的 1.9±0.5 倍。增加细胞外[Ca 2+ ] ,将 PAF 诱导的峰值[Ca 2+ ] i 从 500 增加到 1225 nM,使 NO 产生增加到 193±13%,并进一步将 Lp 增加到对照值的 17.3±1.6 倍。更重要的是,增强的 Ca 2+ 内流恢复了由 AP-CAV 引起的减少的 NO 产生和 Lp,NO FI 为 149%,Lp 为对照值的 7.7±1.1 倍。
我们的结果表明,eNOS 抑制和 NO 产生减少导致 AP-CAV 对 PAF 诱导的通透性增加的抑制作用。CAV 和内皮细胞[Ca 2+ ] i 拮抗调节完整微血管中的 eNOS 活性,产生的 NO 的水平是炎症过程中通透性增加程度的关键决定因素。